Latest / JACC Specialty Journals
Ambrisentan for Early-Stage Low-Risk Pulmonary Arterial Hypertension: Design of the Randomized, Double-Blind, Placebo-Controlled ALEPH Trial | JACC Asia
Commentary by Dr. Jian'an Wang.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.